Physician profile
David Cohen
NPI 1710960794
$4,311.75
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,505 · 2020: $1,003 · 2021: $722 · 2022: $959 · 2024: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,144.45 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,031.03 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $376.65 | 2019-2022 | |
| Insmed, INC. | $265.20 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $216.08 | 2019-2020 | |
| Mylan Specialty L.P. | $195.39 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $163.10 | 2019-2022 | |
| Tg Therapeutics, INC. | $123.19 | 2024 | |
| Grifols USA, LLC | $98.19 | 2019-2022 | |
| Genzyme Corporation | $92.20 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $88.96 | 2022 | |
| Genentech USA, INC. | $71.38 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $68.77 | 2019-2020 | |
| Advanced Respiratory, INC | $62.81 | 2019 | |
| Vapotherm INC | $43.19 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $42.44 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.83 | 2019 | |
| Shionogi INC | $31.08 | 2022 | |
| Philips North America LLC | $26.24 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $22.61 | 2019 | |
| Daiichi Sankyo INC. | $19.71 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.44 | 2019 | |
| Astellas Pharma US INC | $18.74 | 2019 | |
| Allergan, INC. | $15.83 | 2019 | |
| Sanofi Pasteur INC. | $14.56 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.92 | 2020 | |
| United Therapeutics Corporation | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.